Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report

dc.creatorMarin Cardenas, Jorge Alonso
dc.creatorOrtega, Mayra Alexandra
dc.creatorSanchez, Isaura Pilar
dc.creatorPacheco, Jose Armando
dc.creator.mailes
dc.date.accessioned2021-12-16T22:15:26Z
dc.date.available2021-12-16T22:15:26Z
dc.date.issued2017
dc.description.abstractDrug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a hypersensitivity reaction associated with a variety of drugs, mainly anticonvulsants, which is characterized by systemic symptoms and erythematous lesions, common to other toxicodermas. It is an uncommon clinical entity that requires a high suspicion by clinical staff given its varied initial presentation, and the fact that symptoms can overlap with those of other adverse cutaneous reactions to drugs. Without early diagnosis and appropriate treatment, mortality increases.We report the case of a 22-year-old patient with impaired neurodevelopment who received treatment with carbamazepine. Two months later he presented with general symptoms and skin erythematous lesions that began on his trunk. The patient received outpatient care with antihistamines and antipyretics without an appropriate response. His case progressed with increased skin lesions and systemic symptoms that met the diagnostic criteria for DRESS syndrome. He was hospitalized and received medical treatment according to recommended guidelines. The patient's condition improved as his symptoms and associated complications resolved. He was discharged with gradual clearing of the steroid therapy.es
dc.description.orcides
dc.format.extent157-150es
dc.identifierhttps://doi.org/10.7705/biomedica.v37i3.3170
dc.identifierhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074013288&doi=10.12804%2frevistas.urosario.edu.co%2fapl%2fa.7965&partnerID=40&md5=1efd45e110d1b3f9abde41451911c4bc
dc.identifier.bibliographicCitationMARIN JA,Ortega MA,Sánchez IP,Pacheco JA. Drug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case report. Biomedica. 2017. 37. (2):p. 150-157. .es
dc.identifier.issn01204157es
dc.identifier.urihttp://hdl.handle.net/20.500.12494/41344
dc.publisherInstituto Nacional de Saludes
dc.relation.ispartofBiomedica: Revista Del Instituto Nacional De Saludes
dc.rights.accessRightsDesconocidoes
dc.subjectDrug hypersensitivity syndromees
dc.subjecteosinophiliaes
dc.subjectsigns and symptomses
dc.subjectcarbamazepinees
dc.subjectanticonvulsantses
dc.subjecthypersensitivityes
dc.titleDrug rash with eosinophilia and systemic symptoms syndrome induced by carbamazepine: Case reportes
dc.typeArtículo
Archivos